Aimei Health Technology (NASDAQ:AFJK – Get Free Report) and Currenc Group (NASDAQ:CURR – Get Free Report) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.
Profitability
This table compares Aimei Health Technology and Currenc Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aimei Health Technology | N/A | -33.32% | 2.91% |
| Currenc Group | -48.74% | N/A | -18.15% |
Earnings and Valuation
This table compares Aimei Health Technology and Currenc Group”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aimei Health Technology | N/A | N/A | $1.06 million | $0.18 | 237.36 |
| Currenc Group | $37.81 million | 6.16 | -$18.43 million | ($0.30) | -10.20 |
Aimei Health Technology has higher earnings, but lower revenue than Currenc Group. Currenc Group is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 56.0% of Currenc Group shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by company insiders. Comparatively, 17.8% of Currenc Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings and price targets for Aimei Health Technology and Currenc Group, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aimei Health Technology | 1 | 0 | 0 | 0 | 1.00 |
| Currenc Group | 1 | 1 | 0 | 0 | 1.50 |
Risk & Volatility
Aimei Health Technology has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Comparatively, Currenc Group has a beta of 0.17, indicating that its share price is 83% less volatile than the S&P 500.
Summary
Aimei Health Technology beats Currenc Group on 6 of the 11 factors compared between the two stocks.
About Aimei Health Technology
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
About Currenc Group
Currenc Group, Inc. engages in operating a fintech banking platform. It operates through the following segments: Remittance Services, Sales of Airtime, and Other Services. The company is headquartered in Singapore.
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.
